Cowan C L, Cohen R A
Robert Dawson Evans Memorial Department of Clinical Research, Boston University Medical Center, Massachusetts 02118.
Am J Physiol. 1991 Sep;261(3 Pt 2):H830-5. doi: 10.1152/ajpheart.1991.261.3.H830.
The role of nitric oxide and guanosine 3',5'-cyclic monophosphate (cGMP) accumulation in the endothelium-dependent relaxation of the porcine coronary artery to bradykinin was investigated by comparing relaxation and cGMP accumulation in the presence or absence of NG-monomethyl-L-arginine (L-NMMA) and methylene blue. Rings were treated with indomethacin to eliminate the effects of prostaglandins. Relaxation to bradykinin of rings contracted with the thromboxane A2 mimetic U-46619 was not affected by L-NMMA and was only minimally inhibited by methylene blue. Rings contracted with elevated potassium (25 mM) also relaxed completely to bradykinin. However, L-NMMA or methylene blue effectively inhibited relaxation to bradykinin in rings contracted with potassium. cGMP accumulation was stimulated by bradykinin and inhibited by L-NMMA or methylene blue in rings contracted with either U-46619 or potassium. These results suggest that in the absence of nitric oxide-induced cGMP accumulation, a nonprostanoid mechanism exists that is capable of completely relaxing U-46619-contracted coronary artery. This mechanism is either inhibited in or unable to relax potassium-contracted rings. These results also demonstrate that nitric oxide mediates the bradykinin-induced cGMP accumulation that is largely responsible for the relaxation during contraction with potassium.
通过比较在存在或不存在 NG-单甲基-L-精氨酸(L-NMMA)和亚甲蓝的情况下的舒张情况和环磷酸鸟苷(cGMP)积累,研究了一氧化氮和 cGMP 积累在猪冠状动脉对缓激肽的内皮依赖性舒张中的作用。用吲哚美辛处理血管环以消除前列腺素的影响。用血栓素 A2 类似物 U-46619 收缩的血管环对缓激肽的舒张不受 L-NMMA 的影响,仅被亚甲蓝轻微抑制。用高钾(25 mM)收缩的血管环对缓激肽也完全舒张。然而,L-NMMA 或亚甲蓝有效抑制了用钾收缩的血管环对缓激肽的舒张。在用 U-46619 或钾收缩的血管环中,缓激肽刺激 cGMP 积累,而 L-NMMA 或亚甲蓝抑制 cGMP 积累。这些结果表明,在不存在一氧化氮诱导的 cGMP 积累的情况下,存在一种非前列腺素机制,该机制能够使 U-46619 收缩的冠状动脉完全舒张。这种机制在用钾收缩的血管环中被抑制或无法使其舒张。这些结果还表明,一氧化氮介导缓激肽诱导的 cGMP 积累,这在很大程度上负责钾收缩期间的舒张。